Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients
- 1 February 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 6 (2) , 319-328
- https://doi.org/10.1517/14656566.6.2.319
Abstract
Hyperphosphataemia is a usual accompaniment of end stage renal disease and dialysis, in the absence of dietary phosphate restriction or supplemental phosphate binders. It is associated with renal o...Keywords
This publication has 12 references indexed in Scilit:
- Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysisClinical Nephrology, 2004
- Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonateNephrology Dialysis Transplantation, 2004
- Hyperphosphataemia in Renal FailureDrugs, 2003
- Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in managementAmerican Journal of Kidney Diseases, 2000
- Intractable life-threatening hyperkalaemia in a diabetic patientNephrology Dialysis Transplantation, 2000
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998
- Are we mismanaging calcium and phosphate metabolism in renal failure?American Journal of Kidney Diseases, 1997
- Cardiac and arterial interactions in end-stage renal diseaseKidney International, 1996
- Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between FacilitiesAmerican Journal of Kidney Diseases, 1990
- Biochemistry of the LanthanidesPublished by Springer Nature ,1990